Skip to content

Investigation about the Related Factors of Altitude Sickness in Qingzang Railway Builders

Investigation about the Related Factors of Altitude Sickness in Qingzang Railway Builders

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RNC-08000101
Enrollment
Unknown
Registered
2008-05-23
Start date
2001-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute altitude sickness (mainly are high altitude pulmonary edema and high altitude cerebral edema)

Interventions

Observation group:The participants are divided into high altitude pulmonary edema, high altitude cerebral edema, high altitude polycythemia and high altitude cardiopathy groups and given different int

Sponsors

China Railway Construction Corporation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Born and live at the altitude below 2500 meters; Aged between 18 and 50 years old; Participate in Qingzang Railway construction between June 2001 and June 2006; Undertake different building work at the altitude between 2800 and 5072 meters; Have been confirmed as healthy participants by medical examinations before coming to the high altitude plateau.

Exclusion criteria

Exclusion criteria: Exclude myocardial infarction, heart failure, pneumonia, chronic obstructive pulmonary disease, primary pulmonary hypertension, acute and chronic cerebral vascular diseases, epilepsy, meningitis, encephalitis, primary or secondary polycythemia, and other disease that needed to be distinguished from acute or chronic altitude sickness.

Design outcomes

Primary

MeasureTime frame
Incidence rate of altitude sickness;High altitude polycythemia;All-cause mortality;Curative rate of altitude sicknes;

Secondary

MeasureTime frame
Genetic factors;Improvement rate;Blood oxygen saturatio;

Countries

China

Contacts

Public ContactTongchun Zhu, Changchun Qiu
zhu_tc@hotmail.com+86 010 51888027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026